Freezes and reductions in National Institutes of Health funding are reverberating beyond universities and research labs to startups in the biotech industry.

A biotech company recently announced that it's implanted another pig kidney into a human recipient. Here's what to know.

Equity markets recently dipped due to concerns of deteriorating macroeconomic conditions, with the latest trigger being ...

Two Massachusetts researchers are among the recipients of an award known as the “Oscars of Science” for their research in ...

Schroder Investment Management Group lifted its holdings in shares of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX – Free ...

BioLife Solutions is poised to benefit from the booming cell and gene therapy sector. Read more to see my investment strategy ...

Not only are biotech stocks subject to the boom-or-bust nature of their therapeutics, but they also operate in a cyclical ...

Former Sen. Kyrsten Sinema told an Arizona House panel in February she's pushing for clinical trials on ibogaine as part of a "passion project." ...

Brown University has reportedly become the fifth university to be targeted by the Trump administration for funding cuts, ...

Engineers have created new technology that can move cells without touching them, enabling critical tasks that currently require large pieces of lab equipment to be carried out on a benchtop device.

Sangamo, which has been having cash problems, will receive $18 million upfront in licensing fees for its AAV capsid that in ...